Oral Delivery of the Vancomycin Derivative FU002 by a Surface-Modified Liposomal Nanocarrier.
Werner J, Umstätter F, Hertlein T, Mühlberg E, Beijer B, Wohlfart S, Zimmermann S, Haberkorn U, Ohlsen K, Fricker G, Mier W, Uhl P.
Werner J, et al. Among authors: hertlein t.
Adv Healthc Mater. 2024 Jun;13(14):e2303654. doi: 10.1002/adhm.202303654. Epub 2024 Mar 1.
Adv Healthc Mater. 2024.
PMID: 38387090